Home LiteratureArticle Details
PMID: 8662790 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

cAMP-mediated growth inhibition in fibroblasts is not mediated via mitogen-activated protein (MAP) kinase (ERK) inhibition. cAMP-dependent protein kinase induces a temporal shift in growth factor-stimulated MAP kinases.

The Journal of biological chemistry ·Vol. 271 ·No. 23 ·1996-06-07 ·Pages 13476-83

McKenzie FR, Pouysségur J

Abstract

Growth factors stimulate fibroblast cell division by activating the recently identified mitogen-activated protein kinase (MAP kinase) signaling cascade. In contrast to our previous work (Kahan, K., Seuwen, K., Meloche, S. and Pouysségur, J. (1992) J. Biol. Chem. 267, 13369-13375), several reports have suggested that an elevation in intracellular cAMP blocks cell proliferation by attenuating MAP kinase activation. Hence we re-examined the effect of a long term increase in intracellular cAMP and therefore cAMP-dependent protein kinase (PKA) activation on the MAP kinase cascade in CCL39 fibroblasts. The concomitant addition of cAMP-elevating agents prostaglandin E, (PGE1) and IBMX did not inhibit the mitogen-mediated activation of p44 MAP kinase. However, a 5-min PGE1/IBMX pretreatment abolished the MAP kinase response, in a manner correlating with the extent of PKA activity. This inhibition was temporal in nature, and while modifying the time course of growth factor-mediated p44 MAP kinase, activation did not diminish the magnitude of the response. Thus the major peak of MAP kinase activity normally present 5 min after alpha-thrombin addition was now evident at 10 min in the presence of PGE1/IBMX. CCL39 cell proliferation is inhibited by elevated cAMP levels. Such an inhibition could reflect either a reduction in the number of cells entering the cell cycle or a delay in the time required to go through the cycle. Bromodeoxyuridine labeling experiments revealed that the cAMP-mediated inhibition of DNA synthesis in CCL39 cells was not due to a delay in S phase entry, but was due to a reduction in the number of cells entering S phase. Thus we conclude that although PKA activation may slightly modify the time course of MAP kinase activation in response to mitogens in CCL39 cells, the PKA-mediated inhibition of cell division occurs through modulation of an intracellular target, distinct from the p42/p44 MAP kinase cascade.

MeSH Terms
1-Methyl-3-isobutylxanthine/pharmacology Alprostadil/pharmacology Animals Calcium-Calmodulin-Dependent Protein Kinases/antagonists & inhibitors,metabolism Carbachol/pharmacology Cell Division/drug effects,physiology Cell Line Cricetinae Cyclic AMP/metabolism Cyclic AMP-Dependent Protein Kinases/metabolism Enzyme Activation/drug effects Fibroblast Growth Factor 2/pharmacology Fibroblasts/cytology,drug effects,metabolism Humans MAP Kinase Kinase Kinases Mitogen-Activated Protein Kinase 3 Mitogen-Activated Protein Kinases Protein Serine-Threonine Kinases/metabolism Recombinant Proteins/pharmacology Thrombin/pharmacology
Chemicals
Recombinant Proteins Fibroblast Growth Factor 2 Carbachol Cyclic AMP Protein Serine-Threonine Kinases Cyclic AMP-Dependent Protein Kinases Calcium-Calmodulin-Dependent Protein Kinases Mitogen-Activated Protein Kinase 3 Mitogen-Activated Protein Kinases MAP Kinase Kinase Kinases Thrombin Alprostadil 1-Methyl-3-isobutylxanthine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
McKenzie F R
Centre de Biochimie, CNRS, Parc Valrose, 06108 Nice, France.
Pouysségur J
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
1996-06-07
Pages
13476-83
Language
English
Region
United States
NLM ID
2985121R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]